LAB

Standard BioTools (LAB)

Standard BioTools Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LAB

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	05 : 34	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NASDAQ:LAB	Standard BioTools Inc
2024/05/29	09 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/29	05 : 01	GlobeNewswire Inc.	Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers	NASDAQ:LAB	Standard BioTools Inc
2024/05/23	08 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/23	05 : 54	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:LAB	Standard BioTools Inc
2024/05/23	05 : 01	GlobeNewswire Inc.	Standard BioTools to Participate in Upcoming Investor Conferences	NASDAQ:LAB	Standard BioTools Inc
2024/05/22	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/22	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/22	06 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/22	06 : 16	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:LAB	Standard BioTools Inc
2024/05/22	06 : 15	Edgar (US Regulatory)	Form DEFC14A - Definitive proxy statement, contested solicitations	NASDAQ:LAB	Standard BioTools Inc
2024/05/20	21 : 00	GlobeNewswire Inc.	Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:LAB	Standard BioTools Inc
2024/05/20	19 : 03	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:LAB	Standard BioTools Inc
2024/05/18	09 : 11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/17	10 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/11	06 : 16	Edgar (US Regulatory)	Form PREC14A - Preliminary proxy statements, contested solicitations	NASDAQ:LAB	Standard BioTools Inc
2024/05/10	05 : 53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LAB	Standard BioTools Inc
2024/05/09	05 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LAB	Standard BioTools Inc
2024/05/09	05 : 01	GlobeNewswire Inc.	Standard BioTools Reports First Quarter 2024 Financial Results	NASDAQ:LAB	Standard BioTools Inc
2024/04/25	21 : 01	GlobeNewswire Inc.	Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth	NASDAQ:LAB	Standard BioTools Inc
2024/04/25	21 : 00	GlobeNewswire Inc.	Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:LAB	Standard BioTools Inc
2024/04/08	21 : 00	GlobeNewswire Inc.	Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	NASDAQ:LAB	Standard BioTools Inc
2024/04/04	05 : 01	GlobeNewswire Inc.	Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	NASDAQ:LAB	Standard BioTools Inc
2024/03/18	21 : 12	GlobeNewswire Inc.	Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	NASDAQ:LAB	Standard BioTools Inc
2024/03/07	09 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/02/29	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LAB	Standard BioTools Inc
2024/02/29	06 : 01	GlobeNewswire Inc.	Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LAB	Standard BioTools Inc
2024/02/27	06 : 15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LAB	Standard BioTools Inc
2024/02/26	22 : 00	GlobeNewswire Inc.	Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	NASDAQ:LAB	Standard BioTools Inc
2024/02/23	07 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc